FLUO FluoGuide A/S

2.904USD29.50 SEK · STO-6.65%Mkt Cap: 47.47M USDP/E: —

FluoGuide A/S, a clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark. The company offers FG001, an urokinase-type plasminogen activator receptor target imaging agent, which is in …

Key Statistics

Company
Market Cap47.47M USD
Enterprise Value45.28M USD
Revenue (TTM)40.06K USD
Gross Profit40.06K USD
Net Income (TTM)-5.79M USD
Revenue/Share0.0026 USD
Last Price2.904 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees6
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINDK0061123312
Valuation
P/E (Trailing)—
P/E (Forward)-4.75
PEG—
EV/EBITDA-9.53
EV/Revenue1130.19
P/S1766.68
P/B15.72
EPS (TTM)-0.64 USD
EPS (Forward)-0.91 USD
52W Range
2.7568% of range4.705
52W High4.705 USD
52W Low2.756 USD
Profitability
Gross Margin100.00%
Oper. Margin-17780.59%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-72.36%
ROA-44.69%
ROIC-870.71%
ROCE-48.23%
Growth
Revenue Growth61.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.42M USD
CapEx (TTM)—
FCF Margin-10450.87%
FCF Yield-8.82%
Net Debt-3.28M USD
Net Debt/EBITDA0.46
Net Debt/FCF—
Balance Sheet
Debt/Equity0.52
Current Ratio1.88
Quick Ratio1.80
Book Value/Sh0.28 USD
Cash/Share0.45 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)5.366 USD
Upside (mean)+84.8%
Target Range4.377 USD – 6.354 USD
4.377+84.8% to mean6.354
# Analysts2
Ownership
Shares Out.16.35M
Float12.27M
Insiders24.94%
Institutions10.47%
Technical
SMA 503.147 (-7.7%)
SMA 2003.575 (-18.8%)
Beta0.42
S&P 52W Chg12.00%
Avg Vol (30d)6.11K
Avg Vol (10d)4.91K
Technical Indicators
RSI (14)46.1
MACD-0.5998
MACD Signal-0.7284
MACD Hist.+0.1286
BB Upper3.140 USD
BB Middle2.960 USD
BB Lower2.780 USD
BB Width12.17%
ATR (14)0.2178 USD
Vol Ratio (20d)1.54x

About FluoGuide (STO: FLUO)

›

FluoGuide (STO: FLUO) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 6 employees.

The shares were at 29.50 SEK on 19 November 2026, down 30.9% over 52 weeks. Its 52-week range is 28.00 SEK to 47.80 SEK: the price is 38.3% below the high and 5.4% above the low.

Its market capitalisation is 482.30M SEK.

FluoGuide reports return on equity of -72.4% and revenue up 61.4% year over year.

It holds more cash than debt, a net cash position of 22.32M DKK. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 2 analysts cover the stock; their mean price target of 54.51 SEK is 84.8% above the current price. The next earnings report is expected on 26 November 2026.